News & Press Releases

Mintz represented ArriVent Biopharma in a $155 Million Series B financing led by Sofinnova Investments and General Catalyst to fund studies of the company's EGFR kinase inhibitor furmonertinib. Members Ed Pease and Private Equity Practice Co-Chair Matthew Simpson led the Mintz team's work on the transaction.

SAN DIEGO – Mintz is pleased to announce that four attorneys have been named San Diego Super Lawyers and three have been recognized as Rising Stars in the 2023 edition of the annual publication.

Boston, MA – Mintz is pleased to announce that Michael T. Renaud, Chair of the Intellectual Property Division, and the firm’s International Trade Commission (ITC) Practice have been shortlisted in the 2023 edition of Managing Intellectual Property’s (MIP) Americas Awards. The awards recognize the “remarkable achievements and developments” of firms, individuals and companies impacting the IP sector over the past year.

The Bond Buyer quoted Member Charles Samuels on the House's introduction of the Investing in Our Communities bill, which would restore the provision that was eliminated by the Trump Administration.

The Wall Street Journal quoted Co-Chair of Mintz's International Practice Larry Naughton  about the prospective uptick in startup mergers and acquisitions following the collapse of Silicon Valley Bank.

BOSTON, TORONTO – Mintz  is pleased to announce its expansion into Canada with the opening of a Toronto office, launched by a team of highly regarded and industry-leading attorneys. The new office will add depth and breadth to Mintz’s global Life Sciences practice and will further expand the firm’s strong Private Equity, Capital Markets, and Pensions and Employment practices.